Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8,603.00 JPY | +0.21% | -3.06% | -18.65% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 333B | 328B | 300B | 289B | 300B | |||||
Total Revenues | 333B | 328B | 300B | 289B | 300B | |||||
Cost of Goods Sold, Total | 88.61B | 88.7B | 88.68B | 83.62B | 89.21B | |||||
Gross Profit | 244B | 239B | 212B | 206B | 211B | |||||
Selling General & Admin Expenses, Total | 188B | 195B | 186B | 178B | 190B | |||||
Provision for Bad Debts | - | - | 381M | 105M | 108M | |||||
Depreciation & Amortization - (IS) | 3.76B | 4.05B | 5.02B | 4.92B | 5.06B | |||||
Other Operating Expenses, Total | 192B | 199B | 191B | 184B | 195B | |||||
Operating Income | 52.41B | 40.23B | 20.62B | 22.02B | 15.88B | |||||
Interest Expense, Total | -2M | -7M | -17M | -60M | -11M | |||||
Interest And Investment Income | 650M | 662M | 1.12B | 792M | 1.35B | |||||
Net Interest Expenses | 648M | 655M | 1.1B | 732M | 1.34B | |||||
Currency Exchange Gains (Loss) | 574M | -517M | 4.32B | 4.31B | 1.98B | |||||
Other Non Operating Income (Expenses) | 354M | 561M | 1.53B | 1.34B | 1.05B | |||||
EBT, Excl. Unusual Items | 53.98B | 40.93B | 27.58B | 28.39B | 20.25B | |||||
Gain (Loss) On Sale Of Investments | 744M | -197M | -25M | -50M | 1M | |||||
Gain (Loss) On Sale Of Assets | -460M | -410M | -337M | -140M | -217M | |||||
Asset Writedown | -108M | -76M | -148M | -171M | -193M | |||||
Other Unusual Items | 787M | 117M | -543M | -165M | -337M | |||||
EBT, Incl. Unusual Items | 54.95B | 40.36B | 26.52B | 27.87B | 19.5B | |||||
Income Tax Expense | 15.95B | 12.53B | 9.7B | 8.4B | 6.97B | |||||
Earnings From Continuing Operations | 39B | 27.83B | 16.82B | 19.47B | 12.53B | |||||
Net Income to Company | 39B | 27.83B | 16.82B | 19.47B | 12.53B | |||||
Minority Interest | -2B | -1.15B | -178M | -700M | -868M | |||||
Net Income - (IS) | 37B | 26.68B | 16.65B | 18.77B | 11.66B | |||||
Net Income to Common Incl Extra Items | 37B | 26.68B | 16.65B | 18.77B | 11.66B | |||||
Net Income to Common Excl. Extra Items | 37B | 26.68B | 16.65B | 18.77B | 11.66B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 648.7 | 467.75 | 291.79 | 329.02 | 204.41 | |||||
Basic EPS - Continuing Operations | 648.7 | 467.75 | 291.79 | 329.02 | 204.41 | |||||
Basic Weighted Average Shares Outstanding | 57.04M | 57.04M | 57.05M | 57.05M | 57.06M | |||||
Net EPS - Diluted | 648.7 | 467.75 | 291.79 | 329.02 | 204.41 | |||||
Diluted EPS - Continuing Operations | 648.7 | 467.75 | 291.79 | 329.02 | 204.41 | |||||
Diluted Weighted Average Shares Outstanding | 57.04M | 57.04M | 57.05M | 57.05M | 57.06M | |||||
Normalized Basic EPS | 556.47 | 428.29 | 299 | 298.76 | 206.62 | |||||
Normalized Diluted EPS | 556.47 | 428.29 | 299 | 298.76 | 206.62 | |||||
Dividend Per Share | 180 | 190 | 180 | 140 | 140 | |||||
Payout Ratio | 26.21 | 40.62 | 54.83 | 39.51 | 68.48 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 61.23B | 49.86B | 31.86B | 32.72B | 26.46B | |||||
EBITA | 53.21B | 41.03B | 21.42B | 22.98B | 16.9B | |||||
EBIT | 52.41B | 40.23B | 20.62B | 22.02B | 15.88B | |||||
Effective Tax Rate - (Ratio) | 29.02 | 31.05 | 36.57 | 30.13 | 35.75 | |||||
Normalized Net Income | 31.74B | 24.43B | 17.06B | 17.04B | 11.79B | |||||
Non-Cash Pension Expense | -369M | -959M | -941M | -1.52B | -1.22B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 84.91B | 86.92B | 52.23B | 69.93B | 74.04B | |||||
Selling and Marketing Expenses | 98.94B | 102B | 94.74B | 87.35B | 92.86B | |||||
Research And Development Expense From Footnotes | 5.4B | 6.3B | 10.36B | 6.09B | 6.46B |